Eversept Partners, LP Repligen Corp Transaction History

Eversept Partners, LP

  • $991 Million
  • Q4 2024

A detailed history of Eversept Partners, LP transactions in Repligen Corp stock. As of the latest transaction made, Eversept Partners, LP holds 54,066 shares of RGEN stock, worth $8.6 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
54,066
Previous 163,593 66.95%
Holding current value
$8.6 Million
Previous $24.3 Million 68.03%
% of portfolio
0.79%
Previous 1.93%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$123.41 - $160.92 $13.5 Million - $17.6 Million
-109,527 Reduced 66.95%
54,066 $7.78 Million
Q3 2024

Nov 14, 2024
SELL
$119.79 - $167.35 $3.68 Million - $5.14 Million
-30,698 Reduced 15.8%
163,593 $24.3 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $22.3 Million - $34 Million
186,054 Added 2258.76%
194,291 $24.5 Million
Q1 2024

May 15, 2024
SELL
$170.78 - $208.42 $298,352 - $364,109
-1,747 Reduced 17.5%
8,237 $1.51 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $704,314 - $1.14 Million
-6,169 Reduced 38.19%
9,984 $1.8 Million
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $6.93 Million - $8.81 Million
-49,914 Reduced 75.55%
16,153 $2.57 Million
Q2 2023

Nov 08, 2023
BUY
$138.42 - $180.31 $8.36 Million - $10.9 Million
60,411 Added 1068.09%
66,067 $9.35 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $8.36 Million - $10.9 Million
60,411 Added 1068.09%
66,067 $9.35 Million
Q1 2023

Nov 08, 2023
SELL
$154.26 - $198.1 $7.92 Million - $10.2 Million
-51,348 Reduced 90.08%
5,656 $952,000
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $7.92 Million - $10.2 Million
-51,348 Reduced 90.08%
5,656 $952,000
Q4 2022

Nov 08, 2023
BUY
$162.42 - $220.56 $8.67 Million - $11.8 Million
53,363 Added 1465.61%
57,004 $9.65 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $8.67 Million - $11.8 Million
53,363 Added 1465.61%
57,004 $9.65 Million
Q3 2022

Nov 08, 2023
SELL
$160.42 - $256.21 $329,181 - $525,742
-2,052 Reduced 36.04%
3,641 $681,000
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $329,181 - $525,742
-2,052 Reduced 36.04%
3,641 $681,000
Q2 2022

Nov 08, 2023
SELL
$140.68 - $188.02 $4.34 Million - $5.8 Million
-30,828 Reduced 84.41%
5,693 $924,000
Q2 2022

Aug 15, 2022
SELL
$140.68 - $188.02 $4.34 Million - $5.8 Million
-30,828 Reduced 84.41%
5,693 $925,000
Q1 2022

Nov 08, 2023
SELL
$161.19 - $257.96 $4.76 Million - $7.62 Million
-29,546 Reduced 44.72%
36,521 $6.87 Million
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $5.15 Million - $8.24 Million
31,937 Added 696.71%
36,521 $6.87 Million
Q4 2021

Nov 08, 2023
BUY
$247.59 - $304.47 $45,061 - $55,413
182 Added 4.13%
4,584 $1.21 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $45,061 - $55,413
182 Added 4.13%
4,584 $1.21 Million
Q3 2021

Nov 08, 2023
BUY
$194.77 - $324.21 $138,286 - $230,189
710 Added 19.23%
4,402 $1.27 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $138,286 - $230,189
710 Added 19.23%
4,402 $1.27 Million
Q2 2021

Nov 08, 2023
BUY
$165.87 - $220.95 $375,529 - $500,230
2,264 Added 158.54%
3,692 $736,000
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $375,529 - $500,230
2,264 Added 158.54%
3,692 $737,000
Q1 2021

Nov 08, 2023
SELL
$180.37 - $226.26 $11.7 Million - $14.6 Million
-64,639 Reduced 97.84%
1,428 $277,000
Q1 2021

May 13, 2021
BUY
$180.37 - $226.26 $257,568 - $323,099
1,428 New
1,428 $278,000

Others Institutions Holding RGEN

# of Institutions
481
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.82B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email